Identifying predictive biomarkers of CIMAvaxEGF success in non–small cell lung cancer patients

BACKGROUND: Immunosenescence biomarkers and peripheral blood parameters are evaluated separately as possible predictive markers of immunotherapy. Here, we illustrate the use of a causal inference model to identify predictive biomarkers of CIMAvaxEGF success in the treatment of Non–Small Cell Lung Ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzo-Luaces, Patricia, Sanchez, Lizet, Saavedra, Danay, Crombet, Tania, Van der Elst, Wim, Alonso, Ariel, Molenberghs, Geert, Lage, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433036/
https://www.ncbi.nlm.nih.gov/pubmed/32807114
http://dx.doi.org/10.1186/s12885-020-07284-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433036/
https://www.ncbi.nlm.nih.gov/pubmed/32807114
http://dx.doi.org/10.1186/s12885-020-07284-4

Ejemplares similares